The data was presented virtually at the American Academy of Neurology annual meeting
But deliveries to the EU and Switzerland are not affected by the supply issues
New post hoc data comes from phase 3 ASCLEPIOS trials
Pharma company has abandoned drug due to technical, clinical and regulatory uncertainties
Decision made after recommendation from Independent Data Monitoring Committee
PD-1 inhibitor improved overall survival compared to chemotherapy medication docetaxel
Results from the first stage of the Com-Cov trial are expected next month
Booster vaccine candidate increase neutralising titers against SARS-CoV-2 variants of concern in preclinical study
Trial included patients with pancreatic, colon, breast and salivary cancer
Why big pharma paradigm needs to change
How life science and healthcare clusters are driving innovation
The challenges and rewards of meeting consumer expectations
Early treatment with inhaled budesonide could help high-risk patients
BMS releases new data from its phase 3 CHECKMATE-648 study
Combination increases complete response rate to 24% compared to chemotherapy alone
Early preclinical data presented at virtual American Association of Cancer Research meeting
REGEN-COV reduced the risk of symptomatic infections by 81% in a phase 3 prevention trial
French pharma company's acquisition of pre-clinical stage biotech includes mRNA-based research platform
Merck announces results from its phase 3 KEYNOTE-564 trial
Clyburn joined the company in 2008, most recently serving as chief commercial officer for human health
Ahmadi joined Genmab in 2017, previously serving as senior vice president, head of oncology
The AMR Action Fund is aiming to strengthen and accelerate antibiotic development
Frazier is handing the reins over to current Merck CFO Robert Davis
Osborne has previously worked at Ipsos and IQVIA
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...